Our results demonstrated that patients with high WHSC1 expression level showed shorter metastasis-free survival (MFS) times than patients with low levels of WHSC1, which indicated that WHSC1 might be associated with the risk of CRC progression and could be an independent predictor of MFS (Fig. 1c). Here, NSD2 is linked to colorectal carcinoma.